Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New navigation items were added (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study). The Intervention label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', the revision tag updated to v3.6.0, and a recruitment note indicates no more participants are being sought.
    Difference
    0.3%
    Check dated 2026-06-14T01:17:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision label was updated to Revision: v3.5.5, replacing the previous v3.5.4. This reflects a small administrative update to the page rather than changes to its substantive content.
    Difference
    0.0%
    Check dated 2026-06-06T19:19:33.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s text or formatting rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-16T09:22:30.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s UI/backend revision label was updated from version v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T22:24:27.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T14:02:08.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a new MeSH term 'Primary interstitial lung disease specific to childhood' and a Genetic and Rare Diseases Information Center resources link to the study page.
    Difference
    0.1%
    Check dated 2026-04-03T05:57:45.000Z thumbnail image

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.